\n\nIn your clinical practice, how early are you introducing SGLT2 inhibitors into the journey of the non-diabetic chronic kidney disease patient, and how do you manage the concern over the initial drop in glomerular filtration at the start of treatment
CrossRef Prediction of Cancer Incidence and Mortality in Korea, 2026 Kyu-Won Jung, Mee Joo Kang, Eun Hye Park, E Hwa Yun, Hye-Jin Kim, Jeong-Eun Kim, Kui Sun Choi, Han-Kwang Yang Cancer Research and Treatment.2026
Evaluating semaglutides renal safety profile: Data from real-world studies
Radiation inflammation is the most common long-term complication during iodine therapy, often manifesting as dry mouth, altered taste, and dental caries ( Although there are no recommendations for the addition of compounds containing Se to the medical therapy of thyroid cancer, their anticancer properties have attracted attention